223
Views
10
CrossRef citations to date
0
Altmetric
Original Research

The Magnitude of Hematological Abnormalities Among COVID-19 Patients in Addis Ababa, Ethiopia

ORCID Icon, , , , , ORCID Icon, , , ORCID Icon, , , ORCID Icon & ORCID Icon show all
Pages 545-554 | Published online: 02 Mar 2021

References

  • Firas A, Rabi MSAZ, Kasasbeh GA, Salameh DM, Amjad DA-N. SARS-CoV-2 and coronavirus disease 2019: what we know so far. Pathogens. 9(3):231.
  • Zu ZY, Jiang MD, Xu PP, et al. Coronavirus disease 2019 (COVID-19): a perspective from China. Radiology. 2020;200490.
  • Guo Y-R, Cao Q-D, Hong Z-S, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak–an update on the status. Mil Med Res. 2020;7(1):1–10.
  • Adhikari SP, Meng S, Wu Y-J, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review Infectious Diseases of Poverty. 2020;9(1):1–12.
  • WHO. Novel Corona virus (2019-nCov) situation report 2020. Available from: https://www.who.int/timorleste/emergencies/novel-coronavirus-2019/novel-coronavirus-(2019-ncov)-situation-reports. Accessed February 24, 2021.
  • Worldometer CV Reported cases and deaths by country, territory and conveyance. Available from: https://www.worldometers.info/coronavirus/?utm_campaign=homeAdvegas1?%20. Accessed February 24, 2021.
  • Gavriatopoulou M, Korompoki E, Fotiou D, et al. Organ-specific manifestations of COVID-19 infection. Clinical and Experimental Medicine. 2020;20(4):493-506.
  • Ins ET, Elalamy I, Kastritis E, et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020;95:834–847. doi:10.1002/ajh.25829
  • Xu H, Zhong L, Deng J, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020;12.
  • Terpos E, Ntanasis‐Stathopoulos I, Elalamy I, et al. Hematological findings and complications of COVID‐19. Am J Hematol. 2020;95(7):834-847.
  • Prevention CfDCa. Interim clinical guidance for management of patients with confirmed Coronavirus Disease (COVID-19) 2020. Available from: gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html.https://www.cdc. Accessed February 24, 2021.
  • Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–1720. doi:10.1056/NEJMoa2002032
  • Agbuduwe C, Basu S. Haematological manifestations of COVID-19: from cytopenia to coagulopathy. Eur J Haematol. 2020;105(5):540–546. doi:10.1111/ejh.13491
  • Liao D, Zhou F, Luo L, et al. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study. Lancet Haematol. 2020;7(9):e671–e8. doi:10.1016/S2352-3026(20)30217-9
  • Antonio Russo CM, Starace M, Astorri R, Calò F, Coppola N. Current status of laboratory diagnosis for COVID-19: A narrative review. Infect Drug Resist. 2020;13:2657–2665. doi:10.2147/IDR.S264020
  • WHO. Clinical management of COVID-19: interim guidance, 27 May 2020. World Health Organization. 2020 Available from: https://apps.who.int/iris/handle/10665/332196.
  • WHO. Haemoglobin concentrations for the diagnosis of anemia and assessment of severity: VMNIS Vitamin and Mineral Nutrition Information System. Report of a WHO scientific group. 2011 Available from: http://www.who.int/vmnis/indicators/haemoglobin/en.
  • Tsegaye A,Messele T, Tilahun T, Hailu E, et al. Immunohematological reference ranges for adult ethiopians. Clin Diagnostic Lab Immunol. 1999;6:410–414. doi:10.1128/CDLI.6.3.410-414.1999
  • Lewis SM, Bain BJ, Bates I, Dacie JV. Approach to Diagnosis and Classification of Blood Diseases. 10th ed. Philadelphia, PA, USA: Churchill Livingstone; 2006.
  • Huang CW, Y, Li X, Ren L, et al. Clinical features of patients infected with 2019 Novel Coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi:10.1016/S0140-6736(20)30183-5
  • Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 Novel Coronavirus (SARS–Cov–2) Outside of Wuhan, China: retrospective case series. BMJ. 2020;368:m606. doi:10.1136/bmj.m606
  • Fan BE Ching VCL, Chan SSW, et al. Hematologic parameters in patients with COVID-19 infection. Am J Hematol. 2020;95:131–134.
  • Wang DH, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus–Infected Pneumonia in Wuhan. China Jama. 2020;323:1061–1069. doi:10.1001/jama.2020.1585
  • Liu KF, Fang YY, Deng Y, et al. Clinical Characteristics of Novel Coronavirus Cases in Tertiary Hospitals in Hubei Province. Chin Med J. 2020;133:1025–1031.
  • Artur Słomka MK, Zekanowska E. Coronavirus disease 2019 (COVID–19): A short review on hematological manifestations. Pathogens. 2020;9:6.
  • Arentz M, Yim E, Klaff L, et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA. 2020;323:1612–1614. doi:10.1001/jama.2020.4326
  • Li Q, Cao Y, Chen L, et al. Hematological features of persons with COVID-19. Leukemia. 2020;34(8):2163–2172. doi:10.1038/s41375-020-0910-1
  • Yang X, Yue Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;;8(5):475-481.
  • Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. 2020;71(15):762–768.
  • Gong J, Ou J, Qiu X, et al. A tool to early predict severe 2019-novel coronavirus pneumonia (COVID-19): a multicenter study using the risk nomogram in Wuhan and Guangdong, China. Clinical Infectious Diseases. 2020;71(15):833-840.
  • Zhang B, Zhou X, Qiu Y, et al. Clinical characteristics of 82 death cases with COVID-19. PLoS ONE. 2020;15(7):e0235458. doi: 10.1371/journal.pone.0235458
  • Bellmann-Weiler R, Lanser L, Barket R, et al. Prevalence and predictive value of anemia and dysregulated iron homeostasis in patients with COVID‐19 infection. J Clin Med. 2020;9(8):2429.
  • Tao Z, Jing Xu, Chen W, et al. Anemia is associated with severe illness in COVID‐19: A retrospective cohort study. J Med Virol;2021;93:1478–1488. doi: 10.1002/jmv.26444
  • Cai SH, Liao W, Chen SW, Liu LL, Liu SY, Zheng ZD. Association between obesity and clinical prognosis in patients infected with SARS-CoV-2. Infect Dis Poverty. 2020;9:80. doi:10.1186/s40249-020-00703-5
  • Xu, PP, Tian RH, Luo S, Zu ZY, et al. Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study. Theranostics. 2020;10:6372–6383. doi:10.7150/thno.46833
  • Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–273. doi:10.1038/s41586-020-2012-7
  • Liang J, Nong S, Jiang L, et al. Correlations of disease severity and age with hematology parameter variations in patients with COVID-19 pre- and post-treatment. J Clin Lab Anal. 2021;35:e23609.
  • Bain B, England JMJ. Normal haematological values: sex difference in neutrophil count. Br Med. 1975;1:306–309. doi:10.1136/bmj.1.5953.306